The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tradol Plus 37.5 mg/325 mg Tablets

37.5mg/325 milligram(s) Tablet

Rowex LtdPA0711/256/001

Main Information

Trade NameTradol Plus 37.5 mg/325 mg Tablets
Active SubstancesTramadol hydrochloride
Strength37.5mg/325 milligram(s)
Dosage FormTablet
Licence HolderRowex Ltd
Licence NumberPA0711/256/001

Group Information

ATC CodeN02AJ Opioids in combination with non-opioid analgesics
N02AJ13 opiods in combination with non-opiod analgesics


Licence Issued12/02/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0077-133-014
Interchangeable List DocumentPDF of Interchangeable List
« Back